2 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 2 | Unknown 2 |
Follow Advanced Tumors: new trials by email Literature Review of Advanced Tumors trials Research Report on Advanced Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Locally Advanced/Metastatic Solid Tumors or Lymphoma HLX301 - Advanced Tumors, Lymphoma | Phase 1 / Phase 2 | Unknown | Shanghai Henlius Biotech | 30 | 2022-06-20 | 2023-08-08 |
| A Study of PM1022 in Patients With Advanced Tumors PM1022 - Advanced Tumors | Phase 1 / Phase 2 | Unknown | Biotheus Inc. | 200 | 2022-04-11 | 2023-05-22 |
Lymphoma (1) · Neoplasm Metastasis (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Biotheus Inc. (1) · Shanghai Henlius Biotech (1)
China (2)
Ye Guo (1)